Hypertension Detection: HTN-AI Model for Cardiovascular Risk Stratification

By João L. Carapinha

February 25, 2025

Could a simple ECG improve hypertension detection? A recent article in Nature presented a hypertension detection model, HTN-AI, designed to identify hypertension and stratify the risk of cardiovascular disease (CVD) using 12-lead electrocardiogram (ECG) waveforms. The model was trained on over 750,000 ECGs from more than 100,000 patients and validated in a separate sample of over 56,000 patients. HTN-AI accurately identifies prevalent hypertension, predicts the short-term incidence of hypertension, and shows associations with elevated 24-hour ambulatory blood pressure. It also stratifies the risk of CVD outcomes such as mortality, heart failure, myocardial infarction, stroke, and aortic dissection.

Highlights from the Study

HTN-AI can identify hypertension using only 12-lead ECG waveforms, achieving an area under the receiver operating characteristic curve (AUROC) of 0.803 and 0.771 in internal and external validation samples, respectively. The model stratifies the risk of hypertension-associated CVD, including mortality, heart failure, myocardial infarction, stroke, and aortic dissection, regardless of baseline hypertension status or the presence of overt ECG abnormalities.

High HTN-AI risk corresponds with a higher mean 24-hour systolic blood pressure and greater odds of abnormal 24-hour ambulatory blood pressure monitoring results. HTN-AI shows superior or comparable discrimination to established clinical risk scores, such as the Pooled Cohort Equation, for predicting CVD outcomes. Standard ECG measurements, and saliency maps highlight regions of the ECG contributing to HTN-AI predictions, influencing the model’s predictions.

Why is this important?

Hypertension affects over 1 billion individuals worldwide and is a major modifiable risk factor for CVD. Office blood pressure measurements can be variable and may not accurately reflect ambulatory blood pressure, leading to potential underdiagnosis of ambulatory hypertension.

Guidelines recommend serial blood pressure measurements and ambulatory BP monitoring, but clinicians often do not rigorously implement these in clinical settings. Clinicians widely use ECGs as inexpensive diagnostic tools that provide valuable insights into cardiac health. Deep learning models have previously utilized ECGs to classify various cardiac conditions, including atrial fibrillation, left ventricular systolic dysfunction, and valvular disease.

Next Steps

The use of the hypertension detection model HTN-AI could reduce healthcare costs by identifying patients at high risk of CVD earlier, allowing for more targeted and efficient management of hypertension. This could lead to a reduction in the incidence of costly CVD outcomes. By accurately identifying patients with hypertension and stratifying their risk of CVD, HTN-AI can facilitate early detection and management of hypertension, potentially reducing the incidence of heart failure, myocardial infarction, stroke, and other cardiovascular events.

HTN-AI could be deployed in primary care settings to opportunistically screen for masked hypertension using 12-lead ECGs, prompting further diagnostic testing with ambulatory BP monitoring for those at high risk. This approach could enhance the detection and treatment of ambulatory hypertension, which is often underdiagnosed. Before clinical implementation, prospective validation of the hypertension detection model HTN-AI against gold-standard measures of hypertension, such as 24-hour ambulatory BP monitoring, is necessary to ensure its accuracy and reliability in diverse patient populations.

Reference url

Recent Posts

AAP childhood obesity guidelines
     

Caution Advised: Conflicts in AAP Childhood Obesity Guidelines

Are childhood obesity guidelines driving us toward conflict? 🌍 The recent AAP guidelines suggest weight loss medications for children as young as eight, but undisclosed financial ties to drug manufacturers raise serious questions about credibility.

In this article, we dive into the implications of these conflicts and the evidence gaps surrounding pharmaceutical interventions in pediatric care. Transparency and trust are crucial when it comes to the health of our children—let’s explore what needs to change.

Read more to find out how these guidelines could impact families, clinicians, and healthcare policy.

#SyenzaNews #HealthcareInnovation #HealthcarePolicy

implantable glucose device
         

T1 Diabetes Care with an Implantable Glucose Device

🚀 Are we on the brink of a diabetes breakthrough?

A newly developed implantable glucose device from MIT could revolutionize diabetes management, providing an autonomous solution to prevent life-threatening hypoglycemic episodes. This innovative device combines continuous glucose monitoring with responsive hormone delivery, potentially transforming patient care by reducing the need for constant oversight.

Curious about how this technology could reshape diabetes outcomes and healthcare economics? Dive into the full article for a closer look!

#SyenzaNews #HealthTech #HealthEconomics #Innovation

federated learning governance
      

Federated Learning Governance in Healthcare: A Framework for Ethical and Effective Implementation

🔍 Have you considered how federated learning governance can revolutionize healthcare data collaboration?

In our latest article, we explore the critical principles of federated learning governance, emphasizing its role in managing decentralized health data while protecting patient privacy and improving research quality. Learn about the actionable strategies healthcare organizations can implement to navigate the unique challenges that come with this innovative approach.

Dive deeper into the world of federated learning in healthcare and unlock its potential for ethical and effective data use!

#SyenzaNews #AIinHealthcare #DigitalHealth

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

JOIN NEWSLETTER

© 2025 Syenza™. All rights reserved.